Viewing Study NCT00096304

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-03-02 @ 4:09 AM
Study NCT ID: NCT00096304
Status: TERMINATED
Last Update Posted: 2018-04-10
First Post: 2004-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Sponsor: Medical University of South Carolina
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma of the prostate View
None recurrent prostate cancer View
None stage IV prostate cancer View